000 01716 a2200505 4500
005 20250515074501.0
264 0 _c20080108
008 200801s 0 0 eng d
022 _a0066-4804
024 7 _a10.1128/AAC.01590-06
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMartins, H R
245 0 0 _aImpact of dual infections on chemotherapeutic efficacy in BALB/c mice infected with major genotypes of Trypanosoma cruzi.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cSep 2007
300 _a3282-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAcute Disease
650 0 4 _aAlleles
650 0 4 _aAnimals
650 0 4 _aChagas Disease
_xdrug therapy
650 0 4 _aDrug Resistance
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aFemale
650 0 4 _aFlow Cytometry
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aMicrosatellite Repeats
650 0 4 _aNitroimidazoles
_xtherapeutic use
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aTrypanocidal Agents
_xtherapeutic use
650 0 4 _aTrypanosoma cruzi
_xgenetics
700 1 _aSilva, R Moreira
700 1 _aValadares, H M S
700 1 _aToledo, M J O
700 1 _aVeloso, V M
700 1 _aVitelli-Avelar, D M
700 1 _aCarneiro, C M
700 1 _aMachado-Coelho, G L L
700 1 _aBahia, M T
700 1 _aMartins-Filho, O A
700 1 _aMacedo, A M
700 1 _aLana, M
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 51
_gno. 9
_gp. 3282-9
856 4 0 _uhttps://doi.org/10.1128/AAC.01590-06
_zAvailable from publisher's website
999 _c17173041
_d17173041